AQR Capital Management’s Cymabay Therapeutics CBAY Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q1 | – | Sell |
-22,270
| Closed | -$526K | – | 2528 |
|
2023
Q4 | $526K | Sell |
22,270
-9,839
| -31% | -$232K | ﹤0.01% | 1859 |
|
2023
Q3 | $479K | Sell |
32,109
-8,378
| -21% | -$125K | ﹤0.01% | 1861 |
|
2023
Q2 | $443K | Buy |
+40,487
| New | +$443K | ﹤0.01% | 1826 |
|
2021
Q4 | – | Sell |
-10,578
| Closed | -$39K | – | 2310 |
|
2021
Q3 | $39K | Buy |
+10,578
| New | +$39K | ﹤0.01% | 2229 |
|
2021
Q1 | – | Sell |
-90,221
| Closed | -$518K | – | 2285 |
|
2020
Q4 | $518K | Buy |
+90,221
| New | +$518K | ﹤0.01% | 1764 |
|
2020
Q1 | – | Sell |
-18,335
| Closed | -$36K | – | 2176 |
|
2019
Q4 | $36K | Buy |
+18,335
| New | +$36K | ﹤0.01% | 2104 |
|
2019
Q1 | – | Sell |
-21,993
| Closed | -$173K | – | 2233 |
|
2018
Q4 | $173K | Sell |
21,993
-18,603
| -46% | -$146K | ﹤0.01% | 2101 |
|
2018
Q3 | $450K | Buy |
40,596
+7
| +0% | +$78 | ﹤0.01% | 1986 |
|
2018
Q2 | $545K | Buy |
+40,589
| New | +$545K | ﹤0.01% | 1951 |
|